CLINICAL_TRIALS
guidance
· 2021-03-23
Clinical Trial Update: Clinical Guidelines for APL Treatment [Phase 4]
Summary
Phase 4 clinical guidelines update for acute promyelocytic leukemia (APL).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: PETHEMA Foundation | Conditions: APL | Phase 4 | Status: UNKNOWN